tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Ascendis Pharma initiated with an Outperform at RBC Capital
The FlyAscendis Pharma initiated with an Outperform at RBC Capital
20h ago
AZN
MBX
AstraZeneca initiated with an Outperform at BNP Paribas Exane
PremiumThe Fly
AstraZeneca initiated with an Outperform at BNP Paribas Exane
24h ago
AZN
AstraZeneca’s AGM Approves All Resolutions, Marks Board Changes
PremiumCompany Announcements
AstraZeneca’s AGM Approves All Resolutions, Marks Board Changes
5d ago
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
PremiumThe Fly
Trump plans to announce ‘major’ tariff on pharmaceutical imports, Reuters says
7d ago
AZN
BMY
AstraZeneca’s Oncology Breakthroughs: Buy Rating Backed by Promising Pipeline and Strategic Innovations
PremiumRatings
AstraZeneca’s Oncology Breakthroughs: Buy Rating Backed by Promising Pipeline and Strategic Innovations
9d ago
AZN
AstraZeneca’s Imfinzi combination with chemo approved in EU to treat NSCLC
PremiumThe FlyAstraZeneca’s Imfinzi combination with chemo approved in EU to treat NSCLC
12d ago
AZN
Daiichi Sankyo, AstraZeneca’s Enhertu approved in European Union
Premium
The Fly
Daiichi Sankyo, AstraZeneca’s Enhertu approved in European Union
12d ago
AZN
AstraZeneca’s Imfinzi Regimen Gains EU Approval for Lung Cancer
Premium
Company Announcements
AstraZeneca’s Imfinzi Regimen Gains EU Approval for Lung Cancer
12d ago
EU Approves Enhertu for HER2-Low Breast Cancer Treatment
PremiumCompany Announcements
EU Approves Enhertu for HER2-Low Breast Cancer Treatment
12d ago
AstraZeneca put volume heavy and directionally bearish
PremiumThe Fly
AstraZeneca put volume heavy and directionally bearish
14d ago
AZN
AstraZeneca Announces Share Capital and Voting Rights Update
PremiumCompany Announcements
AstraZeneca Announces Share Capital and Voting Rights Update
15d ago
AstraZeneca’s Promising Pipeline and Strategic Positioning in Lung Cancer Treatment Earns Buy Rating
PremiumRatings
AstraZeneca’s Promising Pipeline and Strategic Positioning in Lung Cancer Treatment Earns Buy Rating
15d ago
AZN
AstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trial
PremiumThe FlyAstraZeneca says AZD0780 demonstrates significant LDL-C reduction in trial
16d ago
AZN
AstraZeneca announces FDA approval of Imfinzi combination
Premium
The Fly
AstraZeneca announces FDA approval of Imfinzi combination
16d ago
AZN
AstraZeneca’s Calquence recommended for approval in EU for treatment of MCL
Premium
The Fly
AstraZeneca’s Calquence recommended for approval in EU for treatment of MCL
16d ago
AZN
AstraZeneca’s Imfinzi approved in US for treatment of adults with MIBC
PremiumThe Fly
AstraZeneca’s Imfinzi approved in US for treatment of adults with MIBC
16d ago
AZN
AstraZeneca’s Calquence Gains EU Recommendation for First-Line Mantle Cell Lymphoma Treatment
PremiumCompany Announcements
AstraZeneca’s Calquence Gains EU Recommendation for First-Line Mantle Cell Lymphoma Treatment
16d ago
AstraZeneca’s Imfinzi Gains FDA Approval for Bladder Cancer Treatment
PremiumCompany Announcements
AstraZeneca’s Imfinzi Gains FDA Approval for Bladder Cancer Treatment
16d ago
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
PremiumThe Fly
RFK Jr. plans to cut 10,000 jobs in HHS, WSJ reports
20d ago
AZN
BMY
BridgeBio announces Japanese MHLW approved acoramidis for treating ATTR-CM
PremiumThe FlyBridgeBio announces Japanese MHLW approved acoramidis for treating ATTR-CM
20d ago
AZN
BBIO
U.S. to end funding for child vaccines in developing countries, NY Times reports
Premium
The Fly
U.S. to end funding for child vaccines in developing countries, NY Times reports
21d ago
AZN
GSK
Large pharma M&A deals stalling amid volatile policies, Reuters reports
Premium
The Fly
Large pharma M&A deals stalling amid volatile policies, Reuters reports
21d ago
AZN
BMY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >